FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886729042> ?p ?o ?g. }

• W2886729042 endingPage "296" @default.
• W2886729042 startingPage "288" @default.
• W2886729042 abstract "Introduction: Multiple-drug resistant bacteria are emerging exponentially in healthcare units, threatening public health and requiring novel therapeutic approaches. In 2017, World Health Organization published a list that frames antimicrobial resistant bacteria into priority levels for research of novel drugs to fight them. Methods & Materials: Antimicrobial resistant ESKAPE ( Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , Enterobacter sp.) and Enterococcus faecalis and Escherichia coli pathogens are present in this list. Representative isolates of each species were used to test the Antibacterial and anti-biofilm formation activities of Etodolac (a Non-Steroidal Anti-Inflammatory Drug, NSAID) at 10 and 1 mM using a broth microdilution technique. Results & Discussion: Statistically significant (p< 0,05) results were observed against all tested gram-positives, particularly anti-biofilm activity against E. faecium . Etodolac had an almost null influence on tested gram-negatives, with the exception of one A. baumannii clinical isolate regarding biofilm formation inhibition. Observed differences deserve further analysis and prospection of the involved mechanisms, to unravel possible novel bacterial targets for drug development. Similar work with other NSAID’s may also be worth exploring to ascertain novel therapeutic applications for these drugs, particularly regarding biofilm formation inhibition, per si or as adjuvants of current antibiotherapy, mainly against gram-positives, as suggested by present work. Conclusion: Already approved drugs in terms of pharmacokinetics and safety may deploy faster solutions for antimicrobial therapy against priority pathogens. Current work intends to bring attention to that possibility, particularly regarding NSAIDs, anti-biofilm formation and top priority pathogens." @default.
• W2886729042 created "2018-08-22" @default.
• W2886729042 creator A5009020428 @default.
• W2886729042 creator A5032973868 @default.
• W2886729042 creator A5039882466 @default.
• W2886729042 creator A5057497270 @default.
• W2886729042 creator A5062453926 @default.
• W2886729042 date "2018-08-31" @default.
• W2886729042 modified "2023-09-30" @default.
• W2886729042 title "Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens" @default.
• W2886729042 cites W1419915611 @default.
• W2886729042 cites W1513036179 @default.
• W2886729042 cites W1597241561 @default.
• W2886729042 cites W1615505989 @default.
• W2886729042 cites W1991848197 @default.
• W2886729042 cites W2006155478 @default.
• W2886729042 cites W2042069290 @default.
• W2886729042 cites W2043690768 @default.
• W2886729042 cites W2113969327 @default.
• W2886729042 cites W2120061656 @default.
• W2886729042 cites W2146157756 @default.
• W2886729042 cites W2147358435 @default.
• W2886729042 cites W2148576643 @default.
• W2886729042 cites W2168519960 @default.
• W2886729042 cites W2398653056 @default.
• W2886729042 cites W2400530759 @default.
• W2886729042 cites W2413690058 @default.
• W2886729042 cites W2558941103 @default.
• W2886729042 cites W2579748466 @default.
• W2886729042 cites W2613021898 @default.
• W2886729042 cites W2741746579 @default.
• W2886729042 cites W2982014955 @default.
• W2886729042 cites W4301763891 @default.
• W2886729042 doi "https://doi.org/10.2174/1874285801812010288" @default.
• W2886729042 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6198408" @default.
• W2886729042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30450142" @default.
• W2886729042 hasPublicationYear "2018" @default.
• W2886729042 type Work @default.
• W2886729042 sameAs 2886729042 @default.
• W2886729042 citedByCount "12" @default.
• W2886729042 countsByYear W28867290422020 @default.
• W2886729042 countsByYear W28867290422021 @default.
• W2886729042 countsByYear W28867290422022 @default.
• W2886729042 countsByYear W28867290422023 @default.
• W2886729042 crossrefType "journal-article" @default.
• W2886729042 hasAuthorship W2886729042A5009020428 @default.
• W2886729042 hasAuthorship W2886729042A5032973868 @default.
• W2886729042 hasAuthorship W2886729042A5039882466 @default.
• W2886729042 hasAuthorship W2886729042A5057497270 @default.
• W2886729042 hasAuthorship W2886729042A5062453926 @default.
• W2886729042 hasBestOaLocation W28867290421 @default.
• W2886729042 hasConcept C104317684 @default.
• W2886729042 hasConcept C176947019 @default.
• W2886729042 hasConcept C2776315533 @default.
• W2886729042 hasConcept C2777058267 @default.
• W2886729042 hasConcept C2777637488 @default.
• W2886729042 hasConcept C2777677444 @default.
• W2886729042 hasConcept C2779489039 @default.
• W2886729042 hasConcept C2779895986 @default.
• W2886729042 hasConcept C2780950330 @default.
• W2886729042 hasConcept C4937899 @default.
• W2886729042 hasConcept C501593827 @default.
• W2886729042 hasConcept C523546767 @default.
• W2886729042 hasConcept C54355233 @default.
• W2886729042 hasConcept C547475151 @default.
• W2886729042 hasConcept C55493867 @default.
• W2886729042 hasConcept C58123911 @default.
• W2886729042 hasConcept C71924100 @default.
• W2886729042 hasConcept C86803240 @default.
• W2886729042 hasConcept C89423630 @default.
• W2886729042 hasConceptScore W2886729042C104317684 @default.
• W2886729042 hasConceptScore W2886729042C176947019 @default.
• W2886729042 hasConceptScore W2886729042C2776315533 @default.
• W2886729042 hasConceptScore W2886729042C2777058267 @default.
• W2886729042 hasConceptScore W2886729042C2777637488 @default.
• W2886729042 hasConceptScore W2886729042C2777677444 @default.
• W2886729042 hasConceptScore W2886729042C2779489039 @default.
• W2886729042 hasConceptScore W2886729042C2779895986 @default.
• W2886729042 hasConceptScore W2886729042C2780950330 @default.
• W2886729042 hasConceptScore W2886729042C4937899 @default.
• W2886729042 hasConceptScore W2886729042C501593827 @default.
• W2886729042 hasConceptScore W2886729042C523546767 @default.
• W2886729042 hasConceptScore W2886729042C54355233 @default.
• W2886729042 hasConceptScore W2886729042C547475151 @default.
• W2886729042 hasConceptScore W2886729042C55493867 @default.
• W2886729042 hasConceptScore W2886729042C58123911 @default.
• W2886729042 hasConceptScore W2886729042C71924100 @default.
• W2886729042 hasConceptScore W2886729042C86803240 @default.
• W2886729042 hasConceptScore W2886729042C89423630 @default.
• W2886729042 hasIssue "1" @default.
• W2886729042 hasLocation W28867290421 @default.
• W2886729042 hasLocation W28867290422 @default.
• W2886729042 hasLocation W28867290423 @default.
• W2886729042 hasLocation W28867290424 @default.
• W2886729042 hasLocation W28867290425 @default.
• W2886729042 hasOpenAccess W2886729042 @default.
• W2886729042 hasPrimaryLocation W28867290421 @default.
• W2886729042 hasRelatedWork W2156716055 @default.

• next